Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greystone Medical Group is a medical technology company specializing in advanced wound care solutions, primarily recognized for its proprietary Sorbact technology. Based in Memphis, Tennessee, the company develops products that utilize a physical, non-chemical mechanism to bind and remove bacteria and fungi from wound beds. This hydrophobic interaction effectively reduces the microbial load without releasing active antimicrobial agents, thereby minimizing the risk of bacterial resistance. Their product line, which includes dressings like Leukomed Sorbact and Cutimed Sorbact, is marketed globally through strategic partnerships with major healthcare companies such as BSN medical and Essity. Greystone's innovations are focused on improving healing outcomes for chronic wounds and preventing surgical site infections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greystone Medical Group.